Product Images Rasagiline
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Rasagiline NDC 16714-770 by Northstar Rxllc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
rasagiline-0.5mg-30s - rasagiline 0.5mg 30s
This is a description of a medicine called Rasagiline Tablets. Each tablet contains rasagiine mesylate equivalent to 0.5 mg rasagiline. The tablets come in a container with NDC code 16714-770-01 and are to be stored at 25°C with excursions permitted between 15° to 30°C (59° to 86°F) following USP-controlled room temperatures. The dosage instructions are not available but are included in the accompanying prescribing information. The Northstar Rx LLC manufactures this medicine, but the Akem Laboratories Ltd produces it. The product is from the year 2005, and the tablets are packaged in a 30-tablet container. The text also includes a trademark for NORTHSTAR, an unvarnished area measuring 40 x 20 mm.*
rasagiline-1mg-30s - rasagiline 1mg 30s
Each tablet of Rasagiline contains 1mg of rasagiine mesylate. This medication is manufactured in India by Alkem Laboratories Lid. and distributed by Northstar Rx LLC. It is recommended to store the tablets at 25°C (77°F), but excursions from 15° to 30°C (59° to 86°F) are permitted. Dosage information should be provided by the prescribing physician. The tablet bottle comes with 30 tablets, and the lot number is DD/230. The product is to be kept in a controlled room temperature accordance to USP requirements.*
rasagiline-str-1 - rasagiline str 1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.